Treatment Outcomes With Nafcillin Versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
Author(s) -
Corey C. Burrelli,
Graham M. Snyder,
Howard S. Gold,
Christopher McCoy,
Monica V. Mahoney,
Elizabeth B. Hirsch
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw172.774
Subject(s) - nafcillin , cefazolin , medicine , staphylococcus aureus , bloodstream infection , microbiology and biotechnology , methicillin resistant staphylococcus aureus , meticillin , staphylococcal infections , antibiotics , micrococcaceae , intensive care medicine , antibacterial agent , penicillin , bacteria , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom